Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

DXD motif-dependent and -independent effects of the chlamydia trachomatis cytotoxin CT166.

Bothe M, Dutow P, Pich A, Genth H, Klos A.

Toxins (Basel). 2015 Feb 17;7(2):621-37. doi: 10.3390/toxins7020621.

2.

Actin re-organization induced by Chlamydia trachomatis serovar D--evidence for a critical role of the effector protein CT166 targeting Rac.

Thalmann J, Janik K, May M, Sommer K, Ebeling J, Hofmann F, Genth H, Klos A.

PLoS One. 2010 Mar 25;5(3):e9887. doi: 10.1371/journal.pone.0009887.

3.

Requirement for the Rac GTPase in Chlamydia trachomatis invasion of non-phagocytic cells.

Carabeo RA, Grieshaber SS, Hasenkrug A, Dooley C, Hackstadt T.

Traffic. 2004 Jun;5(6):418-25.

4.

Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.

Barbieri JT.

Int J Med Microbiol. 2000 Oct;290(4-5):381-7. Review.

PMID:
11111915
5.
6.

Persistent Chlamydia trachomatis infection of HeLa cells mediates apoptosis resistance through a Chlamydia protease-like activity factor-independent mechanism and induces high mobility group box 1 release.

Rödel J, Grosse C, Yu H, Wolf K, Otto GP, Liebler-Tenorio E, Forsbach-Birk V, Straube E.

Infect Immun. 2012 Jan;80(1):195-205. doi: 10.1128/IAI.05619-11. Epub 2011 Oct 24.

7.

Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates.

Carlson JH, Hughes S, Hogan D, Cieplak G, Sturdevant DE, McClarty G, Caldwell HD, Belland RJ.

Infect Immun. 2004 Dec;72(12):7063-72.

8.

Azithromycin treatment modulates the extracellular signal-regulated kinase mediated pathway and inhibits inflammatory cytokines and chemokines in epithelial cells from infertile women with recurrent Chlamydia trachomatis infection.

Srivastava P, Vardhan H, Bhengraj AR, Jha R, Singh LC, Salhan S, Mittal A.

DNA Cell Biol. 2011 Aug;30(8):545-54. doi: 10.1089/dna.2010.1167. Epub 2011 Mar 27.

PMID:
21438755
10.

Characterization of a secreted Chlamydia protease.

Shaw AC, Vandahl BB, Larsen MR, Roepstorff P, Gevaert K, Vandekerckhove J, Christiansen G, Birkelund S.

Cell Microbiol. 2002 Jul;4(7):411-24.

PMID:
12102687
11.

[Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].

Müller-Tidow C, Steur C, Mizuki M, Schwäble J, Brandts C, Berdel WE, Serve H.

Dtsch Med Wochenschr. 2002 Oct 18;127(42):2195-200. German.

PMID:
12397548
12.

HLA-B27 expression does not modulate intracellular Chlamydia trachomatis infection of cell lines.

Young JL, Smith L, Matyszak MK, Gaston JS.

Infect Immun. 2001 Nov;69(11):6670-5.

13.

[Infections with Chlamydia trachomatis].

Stock I, Henrichfreise B.

Med Monatsschr Pharm. 2012 Jun;35(6):209-22; quiz 223-4. Review. German.

PMID:
22808665
14.

Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.

Tabusa H, Brooks T, Massey AJ.

Mol Cancer Res. 2013 Feb;11(2):109-21. doi: 10.1158/1541-7786.MCR-12-0466. Epub 2012 Dec 10.

15.

Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells.

Rajalingam K, Sharma M, Lohmann C, Oswald M, Thieck O, Froelich CJ, Rudel T.

PLoS One. 2008 Sep 1;3(9):e3102. doi: 10.1371/journal.pone.0003102.

16.

Effect of Ureaplasma parvum co-incubation on Chlamydia trachomatis maturation in human epithelial HeLa cells treated with interferon-γ.

Yamazaki T, Matsuo J, Nakamura S, Oguri S, Yamaguchi H.

J Infect Chemother. 2014 Aug;20(8):460-4. doi: 10.1016/j.jiac.2014.04.003. Epub 2014 May 20.

PMID:
24855914
17.

Persistently elevated level of IL-8 in Chlamydia trachomatis infected HeLa 229 cells is dependent on intracellular available iron.

Vardhan H, Dutta R, Vats V, Gupta R, Jha R, Jha HC, Srivastava P, Bhengraj AR, Singh Mittal A.

Mediators Inflamm. 2009;2009:417658. doi: 10.1155/2009/417658. Epub 2009 May 26.

18.

RhoE inhibits cell cycle progression and Ras-induced transformation.

Villalonga P, Guasch RM, Riento K, Ridley AJ.

Mol Cell Biol. 2004 Sep;24(18):7829-40.

19.
20.

Tyrosines 303/343/353 within the Sprouty-related domain of Spred2 are essential for its interaction with p85 and inhibitory effect on Ras/ERK activation.

Meng S, Zhang M, Pan W, Li Z, Anderson DH, Zhang S, Ge B, Wang C.

Int J Biochem Cell Biol. 2012 May;44(5):748-58. doi: 10.1016/j.biocel.2012.01.014. Epub 2012 Jan 25.

PMID:
22305891

Supplemental Content

Support Center